XML 65 R50.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Financial assets and liabilities - Summary of Valuation Processes of Contingent Consideration at Fair Value (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023
--- | --- | ---
Disclosure Of Financial Assets And Liabilities [Abstract] |  |
Fair value of cash or stock payable, dependent on achievement of future late-stage clinical or regulatory targets | $ 16,924 | $ 16,606
Fair value of royalty payments from commercialization of the intellectual property acquired | 612 | 593
Contingent Consideration | $ 17,536 | $ 17,199

X
- Definition Cash or stock payable at fair value, liabilities. + References No definition available. + Details
Name: | meso_CashOrStockPayableAtFairValueLiabilities
Namespace Prefix: | meso_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Contingent considerations. + References No definition available. + Details
Name: | meso_ContingentConsiderations
Namespace Prefix: | meso_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Disclosure of financial assets and liabilities abstract. + References No definition available. + Details
Name: | meso_DisclosureOfFinancialAssetsAndLiabilitiesAbstract
Namespace Prefix: | meso_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty payments at fair value, liabilities. + References No definition available. + Details
Name: | meso_RoyaltyPaymentsAtFairValueLiabilities
Namespace Prefix: | meso_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant